William Plovanic
Stock Analyst at Canaccord Genuity
(3.69)
# 783
Out of 5,090 analysts
161
Total ratings
48.97%
Success rate
7.34%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $428 → $432 | $304.19 | +42.02% | 7 | Nov 24, 2025 | |
| HTFL HeartFlow | Maintains: Buy | $39 → $40 | $28.02 | +42.76% | 3 | Nov 13, 2025 | |
| AORT Artivion | Maintains: Buy | $50 → $51 | $44.77 | +13.92% | 4 | Nov 7, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $9 → $11 | $9.22 | +19.37% | 9 | Nov 6, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $81 → $84 | $87.06 | -3.51% | 28 | Nov 3, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $193 → $212 | $177.31 | +19.56% | 13 | Oct 31, 2025 | |
| DXCM DexCom | Maintains: Buy | $106 → $99 | $66.01 | +49.98% | 9 | Oct 31, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $142 → $147 | $137.79 | +6.68% | 8 | Oct 30, 2025 | |
| ATRC AtriCure | Maintains: Buy | $53 → $64 | $40.61 | +57.62% | 12 | Oct 30, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $132 | $97.51 | +35.37% | 12 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $13.54 | +32.94% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 | $20.81 | +15.33% | 6 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $1.37 | +410.95% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $90.93 | -1.02% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $93.98 | +7.47% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 | $7.07 | +55.59% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $19.80 | +66.67% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $7.24 | +107.31% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $302.54 | -6.13% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $21.59 | +15.79% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $2.03 | +491.13% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $83.34 | -16.01% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $25.77 | +86.26% | 5 | Aug 3, 2023 |
Insulet
Nov 24, 2025
Maintains: Buy
Price Target: $428 → $432
Current: $304.19
Upside: +42.02%
HeartFlow
Nov 13, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $28.02
Upside: +42.76%
Artivion
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $44.77
Upside: +13.92%
CVRx, Inc.
Nov 6, 2025
Maintains: Buy
Price Target: $9 → $11
Current: $9.22
Upside: +19.37%
Edwards Lifesciences
Nov 3, 2025
Maintains: Hold
Price Target: $81 → $84
Current: $87.06
Upside: -3.51%
iRhythm Technologies
Oct 31, 2025
Maintains: Buy
Price Target: $193 → $212
Current: $177.31
Upside: +19.56%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $106 → $99
Current: $66.01
Upside: +49.98%
TransMedics Group
Oct 30, 2025
Maintains: Buy
Price Target: $142 → $147
Current: $137.79
Upside: +6.68%
AtriCure
Oct 30, 2025
Maintains: Buy
Price Target: $53 → $64
Current: $40.61
Upside: +57.62%
Boston Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $132
Current: $97.51
Upside: +35.37%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $13.54
Upside: +32.94%
Sep 29, 2025
Maintains: Buy
Price Target: $24
Current: $20.81
Upside: +15.33%
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $1.37
Upside: +410.95%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $90.93
Upside: -1.02%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $93.98
Upside: +7.47%
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $7.07
Upside: +55.59%
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $19.80
Upside: +66.67%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $7.24
Upside: +107.31%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $302.54
Upside: -6.13%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $21.59
Upside: +15.79%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $2.03
Upside: +491.13%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $83.34
Upside: -16.01%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $25.77
Upside: +86.26%